NO WARRANTY
Information accessed through this web site is presented in summary and interactive form and is not exhaustive. Sepracor Inc. makes no warranties or representations as to its accuracy or completeness. This information is provided "as is" without warranty of any kind, either express or implied, including but not limited to implied warranties of merchantability, fitness for particular purpose, or non-infringement. Some jurisdictions do not allow exclusion of implied warranties so the above exclusion may not apply to you. Certain links on this site lead to sites or sources located on servers maintained by third parties over which Sepracor has no control. Sepracor makes no representation as to the accuracy or any other aspect of the information contained in or on such sites, sources or servers, nor does Sepracor necessarily endorse such sites or sources. Neither Sepracor nor its affiliates or their respective employees shall be liable in any way for any legal claims, whether in contract, tort or otherwise in any way connected with the use or performance of this web site or any information linked or referenced by this site or any other information or World Wide Web site which link to this site.
The information included in (or accessible from) this web site contains forward-looking statements that involve risks and uncertainties, including statements with respect to the safety, efficacy, potential benefits, and successful development of the company's pharmaceuticals under development. Among the factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the submission, acceptance, and approval of regulatory filings; the results of clinical trials with respect to products under development; the scope of the company's patent protection with respect to such product candidates; the commercial success of Sepracor's products; the ability of the company to attract and retain qualified personnel; the performance of Sepracor's licensees; the availability of sufficient funds to continue research and development efforts; and certain other factors that may affect future operating results and are detailed in the company's periodic reports filed with the Securities and Exchange Commission.
NON-COMMERCIAL USE
Sepracor gives you permission to copy pages of OMNARIS.COM documents published herein on the World Wide Web for non-commercial use only, provided any copy of these documents that you make shall retain all copyright and other proprietary notices and any disclaimers contained herein.
COPYRIGHTS/TRADEMARKS
All images, trademarks and text are the property of Sepracor Inc., unless otherwise indicated, and may not be downloaded, distributed, sorted, reused, reported, modified or otherwise used except as provided herein, without the express written permission of Sepracor Inc. All product and service names appearing in a typeface different from that of the surrounding text or with a trademark symbol, including "Sepracor" logo, are trademarks and service marks owned by Sepracor Inc. or its subsidiaries or affiliates or another company. Use of these marks, except as permitted herein, is expressly prohibited. Nothing contained herein shall be construed as conferring, by implication, estoppel or otherwise, any license or right under any patent or trademark of Sepracor or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right under any Sepracor copyright.
NO CONFIDENTIALITY
No confidential relationship shall be established in the event that any user of this World Wide Web site should make any oral, written or electronic response to Sepracor (such as feedback, questions, comments, suggestions, ideas, etc.). Such response and any information submitted therewith shall be considered non-confidential, and Sepracor shall be free to reproduce, publish or otherwise use such information for any purposes whatsoever including, without limitation, the research, development, manufacture, use or sale of products incorporating such information. The sender of any information to Sepracor is fully responsible for its content, including its truthfulness and accuracy and its non-infringement of any other person's proprietary rights.
INDIVIDUAL USAGE OF MEDICAL PRODUCTS
The information provided via this web site concerning medical products is not complete and should not be used as a substitute for a consultation or visit with a physician or other healthcare provider. Should you have any healthcare related questions, please see your physician or other healthcare provider promptly.
Sepracor Inc. may, at any time, revise these Terms and Conditions by updating this page. You are bound by any such revisions and should therefore periodically visit this page to review the then current Terms and Conditions.

IMPORTANT SAFETY INFORMATION
When switching from an oral corticosteroid medication to OMNARIS, patients may experience withdrawal symptoms such as joint or muscle pain, weakness, or depression.
OMNARIS may cause slowed growth in children.
Patients using doses of corticosteroid drugs that weaken the immune system are more susceptible to infection and should avoid exposure to chickenpox or measles.
Rare instances of wheezing, nasal irritation, and eye problems have been reported following the use of nasal sprays. Talk with your doctor if you have a history of eye problems or experience a change in vision.
The most common side effects that may occur with OMNARIS are headache, ear pain, sore throat, and nose bleed. Infections of the nose and throat rarely occurred. If an infection occurs it may require treatment or discontinuation of OMNARIS.
For more information, please see the OMNARIS Full Prescribing Information and the OMNARIS Patient's Instructions for Use.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. The products discussed herein may have different product labeling in different countries. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient. OMNARIS is a medicine used to treat seasonal and year-round nasal allergies. Remember that no medicine is for everyone. Only your doctor can prescribe OMNARIS for you.
![]()
©2008 Sepracor Inc. Marlborough, MA 01752 All rights reserved.
and Sepracor are registered trademarks of Sepracor Inc.
OMNARIS is a trademark of Nycomed GmbH, used with permission.